Moderna's Steps to Establish a Korean Subsidiary

COVID-19 vaccine developed by Moderna <이미지출처: Yonhap News>

[Asia Economy Reporter Choi Dae-yeol] Moderna, the U.S. pharmaceutical company that developed the COVID-19 vaccine, is recruiting personnel to establish a subsidiary in Korea.

According to industry sources on the 2nd, Moderna is hiring an executive-level position (General Manager, GM) for its business in Korea through its website. The company stated in the announcement, "We are looking for a GM to establish and lead a new corporation in Korea," adding, "The GM will be responsible for building the business organization in Korea and overseeing overall management."

Additionally, the company plans to recruit a Director in the pharmacovigilance field to monitor adverse drug reactions. Earlier, the company reportedly announced its intention to establish subsidiaries in Korea, Japan, and Australia last month.

While the possibility of contract manufacturing (CMO) has been mentioned, the specific role of the Korean subsidiary has not yet been disclosed. The COVID-19 vaccine developed by the company was added to the World Health Organization's Emergency Use Listing as of the 30th of last month. It is also one of the five vaccines confirmed for introduction in Korea.

This content was produced with the assistance of AI translation services.